Abstract: The murine cytochrome P450 2a5 (Cyp2a5) gene is regulated by complex interactions of various stress-activated transcription factors (TFs). Elevated Cyp2a5 transcription under chemical-induced stress conditions is achieved by interplay between the various TFs -including as aryl hydrocarbon receptor (AhR) and nuclear factor (erythroid-derived 2)-like 2 wild-type (Nrf2) -at the 'stress-responding' cluster of response elements on the Cyp2a5 promoter, as well as through mRNA stabilization mediated by interaction of the stress-activated heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) with the 3 0 -UTR of the CYP2A5 mRNA. We designed a unique toxicity pathway-based reporter assay to include regulatory regions from both the 5 0 and the 3 0 untranslated regions of Cyp2a5 in a luciferase reporter plasmid to reflect in vivo responses to chemical insult. Human breast cancer MCF-7 cells were stably transfected with pGL4.38-Cyp2a5_Wt3k (wild-type) or mutant -pGL4.38-Cyp2a5_StREMut and pGL4.38-Cyp2a5_XREMut -reporter gene to monitor chemical-induced cellular response mediated by AhR and Nrf2 signalling. The recombinant cells were treated with representative of AhR agonist, polycyclic aromatic hydrocarbons, brominated flame retardant, fluorosurfactant, aromatic organic compound and metal, to determine the sensitivity of the Cyp2a5 promoter-based gene reporter assays to chemical insults by measuring the LC 50 and EC 50 of the respective chemicals. The three assays are sensitive to sublethal cellular responses of chemicals, which is an ideal feature for toxicity pathway-based bioassay for toxicity prediction. The wild-type reporter responded well to chemicals that activate crosstalk between the AhR and Nrf2, whilst the mutant reporters effectively gauge cellular response driven by either Nrf2/StRE or AhR/XRE signalling. Thus, the three gene reporter assays could be used tandemly to determine the predominant toxicity pathway of a given compound.
Intensive chemical use in agriculture, growing mining activities, urban sprawl and industrial waste and spills have resulted in a range of contaminants being found in the land and waterways. This has made constant monitoring and risk assessment of the environment critical in ensuring public health safety. Conventional monitoring methods have, until recently, almost entirely consisted of chemical analysis. The limitation of monitoring contaminants solely through chemical analysis is that a range of unidentified contaminants may be missed. Secondly, chemical analysis does not identify the accumulative effect that mixtures of chemicals in the same source may have on living organisms. Considering these shortcomings, several cell-based bioassays have been developed to measure general toxicity and specific toxicity (toxicity pathway-based assays) [1] .
Generally, upon exposure to toxic compounds, the body triggers various toxicity pathways in defence, which include elimination of the compounds (metabolism), recognition of the damage done and repair, and reduction in cellular growth. When the various defence mechanisms are exhausted, cell death ensues. In some cases, metabolism can lead to formation of reactive metabolites that are more toxic than the parent compound, which may overburden the defence mechanisms. These various stages of cellular response are known as toxicity pathways. Synchronized activations of these pathways are driven and controlled by regulatory proteins known as transcription factors (TFs), such as aryl hydrocarbon receptor (AhR), nuclear factor (erythroid-derived 2)-like 2 wild-type (Nrf2), peroxisome proliferator-activated receptor c-coactivator 1a (PGC-1a) and heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1). Upon binding with DNA at specific response elements (RE), TFs initiate the transcription of relevant genes to activate or deactivate toxicity pathways, which in turn determines cell behaviour upon exposure to chemical(s). Exposure intensity and duration dictate the order of activation of the various toxicity pathways. Thus, analysing the functional status of TFs will provide information about the toxicity pathway(s) of chemicals.
The current toxicity pathway-based bioassays were developed on the principle of one toxicity pathway working in isolation [2] . For example, the oxidative stress bioassay was designed by inserting multiple copies of Nrf2 response element (StRE) from the gene encoding glutathione S-transferase a (GSTA) into a reporter gene that encodes light-emitting luciferase protein [3] . The signals from the luciferase protein can be measured and indicative of biological response to a chemical. Similarly, the commercially available carcinogenicity bioassay was designed to include multiple copies of the AhR response element (XRE) from the gene encoding cytochrome P450 1A1 (CYP1A1) into a luciferase reporter gene [4] . This assay is commonly used for quantitative detection of dioxinlike compounds. However, data generated by these bioassays can be misleading due to poor correlation between the assays' responses and in vivo responses to toxic chemicals.
We proposed a unique bioassay design that includes regulatory regions from both the 5 0 and the 3 0 untranslated regions of a gene regulated by various TFs in a reporter gene system to reflect in vivo responses to chemical exposure. An ideal gene for such bioassay is the mouse cytochrome P450 2a5 (Cyp2a5) because its complex regulation involves interaction of the promoter with multiple stress-activated TFs (reviewed in [5] ). The Cyp2a5 promoter contains a 'stress-responding' cluster of REs ( fig. 1A ), which interact with major mediators of toxic insults, including Nrf2 and AhR [6] [7] [8] . These interactions are crucial in the up-regulation of the gene under stress conditions. Additionally, elevated Cyp2a5 transcription could also be achieved through mRNA stabilization mediated by interaction of the stress-activated hnRNP A1 with the 3 0 -UTR of the CYP2A5 mRNA [9] . The up-regulation via enhanced transcription combined with mRNA stabilization, as seen in some of the stress situations, led to a particularly strong, fast and persistent response [10] .
In this study, we described the construction of three Cyp2a5 promoter-based luciferase gene reporter assays in MCF-7 (human breast cancer) cells to monitor chemical-induced cellular response mediated by the AhR and Nrf2 signallings. The first reporter plasmid, pGL4.38-Cyp2a5_Wt3k, contains the 'stress response cluster' from the Cyp2a5 gene promoter, as well as a stress response element from its 3 0 -UTR mRNA region ( fig. 1B) . The second reporter plasmid, pGL4.38-Cyp2a5_S-tREMut, contains a mutated stress response element (StRE) ( fig. 1C ), whilst the third plasmid harbours a mutated XRE ( fig. 1D ). The preliminary results suggest that the three gene reporter assays could be used tandemly to determine the responsiveness of two toxicity pathways to the various test chemicals.
Materials and Methods
Chemicals and cell culture. All chemicals were purchased from Sigma-Aldrich Co. Ltd (Sydney, NSW, Australia), unless otherwise stated. Polyethylenimine (PEI) was obtained from Polysciences Inc.
(Warrington, PA, USA), and Britelite TM plus Reporter Gene Assay System was purchased from PerkinElmer Pty. Ltd (Milton, QLD, Australia). Human cell lines C3A (liver carcinoma) and A549 (lung epithelial) were obtained from the ATCC (Manassas, VA, USA), whilst MCF-7 (human breast carcinoma) was kindly provided by Dr. Greg Monteith, The University of Queensland, Australia. The growth medium for C3A and A549 cells -William's Medium E -and for MCF-7 -DMEM -was supplemented with 10% foetal bovine serum (FBS), 1% Glutamax and 1% penicillin-streptomycin solution. All cells were cultured at 37°C, in 95% air and 5% CO 2 , and passaged every 3-4 days. Cells with passage number between 5 and 20 were used in transfection assays. Growth media and all media supplements for cell culture were sourced from Invitrogen (Scoresby, Vic., Australia).
Reporter plasmids and expression constructs. The Cyp2a5 5 0 -3033/ +10 and the mutant (XRE -2514 to -2492 and StRE -2386 to -2377) fragments of the Cyp2a5 promoter cloned in front of the luciferase cDNA in the pGL3-Basic vector (Promega, Madison, WI, USA) were used in transient transfection assays. These promoter constructspGL3-Wt3k, pGL3-XREMut, and pGL3-StREMut -were kind gifts Fig. 1 . Schematic representation of (A) the current view on the regulatory pathways of Cyp2a5 gene (reviewed in [5] ), (B) the wild-type Cyp2a5 promoter-based gene reporter plasmid, (C) and (D) the mutant Cyp2a5 promoter-based gene reporter plasmid. The functional (C) AhR binding site at position À2514 to À2492 and (D) Nrf2 biding sites at position À2386 to À2377 were mutated by site-directed mutagenesis as described in refs 7 and 6, respectively. The Cyp2a5 promoter segments were cloned between the cloning sites KpnI and XhoI in the pGL4.38[luc2P/Hygro] mammalian expression vector (Promega Corp., Australia) according to the manufacturer's protocol. The Cyp2a5 promoters were then ligated to the truncated end. The vectors were then propagated in the Escherichia coli and purified accordingly. The expected structures of the constructs were verified by sequencing. from Dr. Jukka Hakkola (University of Oulu, Finland), and their constructions are described in detail elsewhere [6, 7, 11] . The pGL3-Wt3k reporter plasmid contains functional AhR (XRE) and Nrf2 (StRE) binding sites located at À2514 to À2492 and À2386 to À2377 of the Cyp2a5 5 0 -flanking region, respectively [6, 7] ( fig. 1A ), whilst the pGL3-XREMut and pGL3-StREMut constructs contain mutated XRE and StRE, respectively [6, 7] .
For stable transfection, the three Cyp2a5 promoter fragments were excised from the respective pGL3-Basic vectors and cloned between the cloning sites KpnI and XhoI in the pGL4.38[luc2P/Hygro] mammalian expression vector (Promega Corp., Australia) according to the manufacturer's protocol. The Cyp2a5 promoters were then ligated to the truncated end. The vectors were then propagated in the Escherichia coli and purified accordingly. The expected structures of the constructs were verified by sequencing. The diagrammatic presentation of each Cyp2a5 promoter-based reporter plasmid -pGL4.38-Cyp2a5_Wt3k, pGL4.38-Cyp2a5_XREMut and pGL4.38-Cyp2a5_S-tREMut -is illustrated in fig. 1B -D.
The expression plasmids pcDNA3-AHR [12] and pcDNA/Neo-ARNT [13] expressing mouse Ahr and Arnt, respectively, were provided by Dr. Oliver Hankinson (UCLA, USA). The expression plasmid pTARGET-Nrf2 [14] expressing human Nrf2 was provided by Dr. Miki Nakajima (Kanazawa University, Japan). The Nrf2 cDNA was then excised from the pTARGET vector and cloned into pcDNA3 vector (Invitrogen).
Transient transfection and analysis of luciferase reporter gene activity. Polyethylenimine (PEI) (Polysciences Inc.) was used to transiently transfect cultured cells with the various promoter constructs. Polyethylenimine stock solution (1 lg/ll) was prepared by dissolving 100 mg of PEI in 100 ml sterilized water at 50°C and pH adjusted to 7 with HCl. The solution was passed through a 0.22-lm filter (Millipore, USA) and stored at -80°C. The PEI solution was warmed up to room temperature prior to transfection assays.
In selecting compatible cell line for stable transfection of the Cyp2a5 promoter-based reporter constructs, C3A, A549 and MCF-7 cells were transiently transfected with the pGL3-Wt3k, pGL3-XREMut and pGL3-StREMut reporter plasmids. Briefly, cells were seeded at a density of 2 9 10 5 per well in 24-well plates and grown in the appropriate medium. After overnight incubation, the cells were washed once in 500 ll PBS and 500 ll fresh FBS-free medium was added to each well. Cells in each well were cotransfected with 0.1 lg of pMAX-GFP (Lonza Corp, Basel, Switzerland) as transfection control and 0.1 lg of pGL3 or 0.1 lg of the respective pGL3-Cyp2a5 promoter plasmid. The DNA:PEI ratio for MCF-7 cells is 1:8 and for C3A and A549 cells is 1:2. The DNA-PEI mixture (maximum 20 ll PEI/well) was incubated at room temperature for 15 min. before being added to each well of the 24-well plates. The transfected cells were cultured for 24 hr before the GFP fluorescent and luciferase luminescence signals were captured on a FLUOstar Omega multimode microplate reader (BMG Labtech, Offenburg, Germany) with automatic gain settings. Transfection under each condition was performed in quadruplet for at least three different experiments.
To test the reporter plasmids responsiveness to AhR/XRE and Nrf2/ StRE signalling activation, after transfection, the culture medium was replaced 24 hr later with fresh growth medium containing various concentrations of tert-butylhydroquinone (tBHQ) or ß-naphthoflavone (BNF) (in a solution giving a final concentration of 0.1% v/v DMSO). The medium-spiked tBHQ/BNF was prepared immediately before each experiment. For control experiments, vehicle alone (0.1% v/v DMSO) was added to the growth medium. Cells were incubated for 24 hr to respond to the chemicals before the luciferase activity and GFP signal were captured on a FLUOstar Omega multimode microplate reader (BMG Labtech, Offenburg, Germany) with automatic gain settings. The relative luciferase activity was calculated by normalizing firefly luciferase activity to the GFP signal. Transfection (with or without treatment with chemicals) under each condition was performed in quadruplet for three different experiments.
Generation of stable Cyp2a5 promoter-driven reporter systems. The pGL4.38-Cyp2a5_Wt3k, pGL4.38-Cyp2a5_XREMut and pGL4.38-Cyp2a5_StREMut containing hygromycin selectable marker were stably transfected into MCF-7 cells using the PEI method in a 10-cm cell culture dish. Transfected cells were selected using 150 lg/ml hygromycin B in the media. After 4 weeks, each stable cell line generated 2-3 healthy clones. These clones were harvested using cloning cylinders. Each clone for each stable cell line was plated on a 12-well plate (one clone/well) and cultured in complete media containing 150 lg/ml hygromycin B. After reaching 80% confluency, the cells were passaged and the reporter activity for each hygromycin-resistant clone was assessed independently by measuring the basal and inducible (treatment with 50 lM tBHQ or 2.5 lM BNF) luciferase activity as described above. Clones with high inducible luciferase activity (more than twofold induction) were used in subsequent experiments. Each experiment was carried out in quadruplet and repeated at least four times independently. The cells used from each experiment were from the aliquot of the same clone of each stable cell line.
Overexpression of AhR and Nrf2 in stable Cyp2a5 promoter-driven reporter cells. Recombinant MCF-7 cells were seeded at a density of 2 9 10 5 per well in 24-well plates and grown in DMEM supplemented with 10% foetal bovine serum (FBS), 1% Glutamax and 150 lg/ml hygromycin B. After overnight incubation, the cells were washed once in 500 ll PBS and 500 ll fresh FBS-free medium was added to each well. Cells in each well were transiently cotransfected with 0.1 lg of pMAX-GFP (as transfection control) and 0.1 lg of pcDNA3 or pcDNA3-AHR and pcDNA/Neo-ARNT, or pcDNA3-hNrf2 using PEI (DNA:PEI is 1:8). The transfected cells were cultured for 24 hr before measurement of the GFP fluorescent, and luciferase luminescence signals were captured on a FLUOstar Omega multimode microplate reader (BMG Labtech, Offenburg, Germany) with automatic gain settings. Transfection under each condition was performed in quadruplet for at least three different experiments.
Treatment of stable Cyp2a5 promoter-driven reporter cells with selected chemicals. In testing the responsiveness of the reporter cells to chemicals, clone #2 of the wild-type cell line and clone #1 of the mutant cell lines were treated with representatives of AhR agonist, polycyclic aromatic hydrocarbon, heavy metal, fluorosurfactant, phenolic antioxidant and brominated flame retardant (Table 1 ). Prior to dose-response studies on luciferase activity (to determine EC 50 ), the cytotoxicity (LC 50 ) of the respective chemicals was determined to justify the concentration range to be used in the dose-response studies.
Briefly, cells were seeded at a density of 2 9 10 4 per well in 96-well plates and grown in DMEM supplemented with 10% foetal bovine serum (FBS), 1% Glutamax and 150 lg/ml hygromycin B and incubated for 24 hr. The cells were then rinsed once with PBS, followed by addition of chemical-spiked medium to each well at different concentrations in 100 ll total volume of complete DMEM with charcoalstripped FBS. Control cells received 0.1% DMSO only. The cells were incubated for 24 hr before the cell proliferation (MTS) assay (Promega Corp., USA) was performed on the same plate by replacing the spent medium with 100 ll fresh FBS-free medium containing 20 ll MTS solution. The number of living cells was represented by optical densitometry readings at 490 nm on a microplate spectrophotometer (Bio-Rad XMark). The LC 50 value of each chemical was then extrapolated from the dose-absorbance curves. Five replicates in at least three different experiments were performed for each tested concentration.
For the dose-response studies to determine EC 50 of the respective chemicals, the cells were treated with six different concentrations (below Western blot analysis. To obtain whole-cell extracts, cells were lysed in extraction buffer containing 10 mM HEPES-KOH (pH 7.4), 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM EDTA and 20% glycerol supplemented with protease inhibitor mixture (Roche Diagnostic, Indianapolis, IN, USA). Nuclear extracts were prepared as described previously [15] . Protein samples (20 lg whole lysate and 10 lg nuclear extracts) were separated by 4%-12% SDS-PAGE (Bio-Rad Laboratories, USA). The proteins were electrophoretically transferred on to Hybond ECL PVDF membranes (Amersham Biosciences Ltd., UK) and blocked overnight in Tris-buffered saline containing 0.1% Tween-20 and 5% non-fat milk. The membranes were then incubated with a mouse monoclonal anti-AhR (ab2770), anti-Nrf2 (ab89443) or anti-ß-actin (ab8224) antibody (Abcam, UK) for 2 hr, washed with TBS-T and incubated for 1 hr with horseradish peroxidase-conjugated goat antimouse IgG (1:3000 dilution). After further washing with TBS-T, the membrane was incubated with luminol solution (1 M Tris pH 8.5, 90 mM p-coumaric acid, 250 mM luminol and 3% H 2 O 2 ) for 5 min. and immunoreactive bands were visualized and captured by the ChemiDoc TM MP imaging system (Bio-Rad Laboratories, USA).
Statistical analysis. The GraphPad Prism software was used to determine LD 50 and EC 50 of the chemicals. Multiple-group comparisons were made with one-way analysis of variance (ANOVA) followed by the Fisher least significant difference post hoc test. Differences were considered significant when p < 0.05.
Results and Discussion
Transient transfection analysis of Cyp2a5 promoter-based reporter assay. Three human cell lines -lung (A549) and hepatocellular (C3A) carcinomas and breast cancer (MCF-7) -were transiently transfected with the three Cyp2a5-luc-promoter systems, pGL3-Wt3k, pGL3-XREMut and pGL3-StREMut, to evaluate the gene reporters' activity and compatibility of the cells for stable transfection. These cell lines were chosen as they substantially express AhR, Nrf2 and other TFs relevant for the basal expression of the Cyp2a5 gene [3, 16] . The transient transfections were successful, with A549 cell line producing the lowest reporter gene activity in all three systems ( fig. 2) . Amongst the three cell lines, MCF-7 is the most compatible and resilient with consistent activity in the three systems (fig. 2) .
The transiently transfected MCF-7 cells were then tested for responsiveness to the AhR/XRE and Nrf2/StRE signalling activations by treating the cells with ß-naphthoflavone (BNF) or tert-butylhydroquinone (tBHQ). Both BNF and tBHQ are AhR ligands that have been shown to regulate Nrf2-responsive genes [17] [18] [19] . Figure 3A -C shows that BNF and tBHQ caused a dose-dependent response in all three systems. These observations were to be expected as BNF and tBHQ are AhR ligands that activate gene expression by promoting binding of the AhR/Arnt complex to the XRE on a gene promoter [17, 19] . Both BNF and tBHQ are also known to regulate Nrf2-responsive genes by activating the Keap1/Nrf2 signalling through the AhR/Arnt axis [18, 20, 21] . It is noted that the induction of the reporter gene activity by BNF and tBHQ correlates with cellular distribution of the Nrf2 and AhR proteins ( fig. 3D,E) . The results suggest that tBHQ induced translocation of cytoplasmic AhR and Nrf2 into the nucleus with equal efficiency (fig. 3E ). By contrast, BNF was more efficient in translocating AhR than Nrf2 ( fig. 3D ). It is noted that unlike cytosolic Nrf2 (whole lysate), the nuclei Nrf2 was not ubiquitinated, as indicated by lower MW ( fig. 3D,E) [22, 23] . Taken together, these observations demonstrate that the Cyp2a5 promoter-based reporter assay was able to reflect the mechanistic responses in MCF-7 culture.
Given that the expression of Cyp2a5 gene can be regulated by the AhR/XRE and Nrf2/StRE signalling pathways [6] [7] [8] and that crosstalk between AhR and Nrf2 is an important factor in the regulation of stress-responsive genes, such as the Cyp2a5 [20, 21, 24] , both BNF and tBHQ can be used as reference compounds to determine the relative potency of chemicals in inducing Cyp2a5-reporter gene activity. However, BNF is more potent than tBHQ in inducing the gene reporter activity as BNF concentration that induced maximum activity is 20-fold less than the tBHQ concentration ( fig. 3A,B) . For this reason, BNF will be used as the reference compound in subsequent experiments that evaluate the sensitivity of the Cyp2a5 promoter-based gene reporter assays on toxicity of selected chemicals.
Generation of a stable cell line expressing Cyp2a5 promoterdriven reporter transgene. Subsequently, the MCF-7 cells were stably transfected with the three pGL4.38-Cyp2a5 reporter plasmids. The intensity of reporter gene activity correlates with the number of cells/well in all recombinant MCF-7 cells (fig. 4) , indicating stable expression of the respective reporter plasmid. The basal expression of luciferase protein in the respective stable cell lines was quite high (RLU > 200 U) and consistent up to passage forty. In the subsequent experiments, induction of luciferase activity by selected chemicals was determined using cells from passage ≤ 20 and the maximum number of cell used = 20,000 cells/well of 96-well plate.
Recombinant MCF-7 cells responses are driven by AhR and Nrf2.
To confirm that the reporter activity of the three recombinant cell lines is driven by the TFs Nrf2 and AhR/Arnt, the recombinant cells were transfected with mammalian expression plasmid of the respective TFs for 24 hr. Overexpression of either Nrf2 or AhR/Arnt in the wild-type recombinant MCF-7 (pGL4.38-Cyp2a5_Wt3k) increased the reporter gene activity by almost fourfold that of control cells ( fig. 5 ), whilst Nrf2 overexpression in cells with mutated Nrf2 binding site (pGL4.38-Cyp2a5_StREMut) did not affect the basal expression of luciferase protein ( fig. 5 ). However, AhR/ Arnt overexpression increased the protein expression by about threefold of control ( fig. 5 ). By contrast, overexpression of Nrf2 increased luciferase activity by more than fivefold in pGL4.38-Cyp2a5_XREMut cells and AhR/Arnt overexpression did not alter the protein expression ( fig. 5 ). These observations indicate that luciferase protein expression in the respective cell lines was driven by the intended TFs, which supports the observations in transiently transfected cells ( fig. 5 ).
Recombinant MCF-7 cells are responsive to chemical-induced cellular response.
To gauge the suitability of the respective recombinant cell for a bioassay to detect cellular response of chemicals, dose-response studies with chemicals listed in Table 1 were undertaken to determine the EC 50 . Prior to dose-response studies, LC 50 values of the respective chemicals were determined to inform the concentration range to be used in the dose-response studies.
The LC 50 values of the test chemicals in all the three recombinant cell lines are similar to the values in the parental MCF-7 cells (table 2). The EC 50 values for all tested chemicals obtained from the wild-type and mutant recombinant cells are well below the LC 50 values (table 2), indicating that the cells are sensitive to sublethal cellular responses, which is an ideal feature for toxicity pathway-based bioassays.
In descending order of potency relative to the reference compound, BNF, in (a) the wild-type cells (pGL4.38- Fig. 2 . Luciferase activity of the reporter systems in A549, C3A and MCF-7 cells. The cells were transiently cotransfected with pmaxGFP vector and empty pGL3 luciferase reporter plasmid, pGL3-Cyp2a3Wt-Luc (pGL3-Wt3k), pGL3-Cyp2a5XREMut-Luc (pGL3-XREMut) or pGL3-Cyp2a5StREMut-Luc (pGL3-StREMut) reporter system in 24-well plate for 24 hr. Thereafter, luciferase activity and green fluorescence were detected. The pmaxGFP vector serves as control to monitor transfection efficiency. Luciferase Activity = Luciferase activity reading/GFP signal reading. The values (n = 4 of 3 different runs) represent the means AE S.D. *Mean difference is significant from control group (pGL3) at p < 0.05 (one-way ANOVA followed by Fisher's least significant difference post hoc test). Fig. 3 . Effects of BNF and tBHQ on the reporter gene activity. MCF-7 cells transiently harbouring luciferase reporter vector containing full-length Cyp2a5 promoter with intact xenobiotic response element (XRE) and antioxidant response element (StRE) (pGL3-Wt3k), or full-length Cyp2a5 promoter with mutated XRE (pGL3-XREMut), or full-length Cyp2a5 promoter with mutated StRE (pGL3-StREMut) were treated with various concentrations of BNF, a AhR agonist (A-C), or treated with various concentrations of tBHQ, an Nrf2 inducer (A-C), for 24 hr. The cells were also transiently transfected with pmaxGFP vector, which serves as control to monitor transfection efficiency. Luciferase Activity = Luciferase activity reading/GFP signal reading. The values represent the means AE S.D. of at least six replicates of at least three separate experiments. *Mean difference is significant from the control group at p < 0.05 (one-way ANOVA followed by Fisher's least significant difference post hoc test). Whole lysate and nuclear extract were obtained from MCF-7 cells treated with either 3 lM BNF, 50 lM tBHQ or 0.1% DMSO. Proteins of whole lysate (20 lg) and nuclear extracts (10 lg) were subjected to 7% SDS-PAGE and transblotted onto PVDF membranes. The levels of Nrf2 and AhR proteins after treatment with BNF (D) or tBHQ (E) were measured by Western immunoblotting. Std = 2 ng recombinant human Nrf2 protein (ab202153; Abcam, Vic., Australia) or 2 ng recombinant human AhR protein (ab112247; Abcam, Vic., Australia). Shown are representative of blots from at least three separate experiments (each blot shows the same pattern of induction). (table 2) . These observations suggest that the three recombinant cells could potentially be used tandemly to determine the predominant toxicity pathway of a given chemical. For example, BaP, a polycyclic aromatic hydrocarbon, is more potent in inducing reporter gene activity in pGL4.38-Cyp2a5_StREMut cells than in either pGL4.38-Cyp2a5_Wt3k or pGL4.38-Cyp2a5_XREMut (table 3) . It is equally potent in inducing activity when both AhR and Nrf2 binding sites are intact (pGL4.38-Cyp2a5_Wt3k), or when only AhR binding site is mutated (pGL4.38-Cyp2a5_XREMut) (table 3). The contribution of AhR binding to this response is about twofold (relative to BNF) that of Nrf2 binding (table 3) . These observations suggest that the predominant responsive pathway of BaP is the AhR/XRE signalling. This aligns with our knowledge that BaP toxicity is through ligand binding, as well as oxidative stress by its reactive metabolites [25] . As MCF-7 cells do not have as much metabolizing enzymes as the liver cells, a huge response in pGL4.38-Cyp2a5_XREMut cells was not expected. per well in 24-well plates. The transfection for each condition was performed in quadruplet for at least three different experiments. *Mean difference is significant from control group at p < 0.05 (one-way ANOVA followed by Fisher's least significant difference post hoc test). Nrf2-and AhR/ Arnt-denote cells transfected with empty pCDNA3 expression vector (controls).
By contrast, the predominant responsive pathway for CdCl 2 , PFOA, TBBPA and tBHQ is the Nrf2/StRE signalling as there was no observable or insignificant induction of reporter activity in the pGL4.38-Cyp2a5_StREMut cells. These observations align with the current understanding of the mechanism of action of these chemicals [26] [27] [28] [29] [30] .
Interestingly, TCDD -another type of AhR agonistrequires both the AhR and Nrf2 to induce the reporter gene activity as exposure of pGL4.38-Cyp2a5_StREMut cells to TCDD resulted in reduction of activity, whilst the basal activity in pGL4.38-Cyp2a5_XREMut cells was not altered (table 2) . However, TCDD is as potent as BNF (also an AhR agonist) in inducing the activity of the wild-type (the basal activity Wt3k) reporter (table 3) . This reflects the importance of crosstalk between AhR and Nrf2 in regulating stressresponsive genes [20, 21, 24] .
Conclusion
In conclusion, the three Cyp2a5 promoter-based gene reporter assays (pGL4.38-Cyp2a5_Wt3k, pGL4.38-Cyp2a5_XREMut and pGL4.38-Cyp2a5_StREMut) in MCF-7 cells are sensitive to sublethal cellular responses of chemicals, which is an ideal feature for toxicity pathway-based bioassays for toxicity prediction.
The wild-type reporter pGL4.38-Cyp2a5_Wt3k that contains functional AhR and Nrf2 binding sites responded well to chemicals that activate crosstalk between the two TFs. The non-functional AhR binding site reporter (pGL4.38-Cyp2a5_XREMut) could be used to gauge cellular response driven by oxidative stress, whilst the non-functional Nrf2 binding site reporter (pGL4.38-Cyp2a5_StREMut) could detect biological response driven by AhR ligand binding. The preliminary results indicated that the three gene reporter assays could be used tandemly to determine the predominant toxicity pathway(s) of polycyclic aromatic hydrocarbons, brominated flame retardant, fluorosurfactant, aromatic organic compound and metal. Indeed, the potential clinical and environmental application of these bioassays is worth exploring to enhance the capability of existing in vitro toxicity methods in contributing to assessing risks to human beings and the environment. We are currently validating the effectiveness of theses assays in predicting toxicity pathway(s) of chemicals in environmental samples and new drug candidates. 
